Stockholm-listed biopharmaceutical company Wilson Therapeutics, backed by a consortium of private equity investors including HealthCap, has been sold to US-based pharmaceutical company Alexion Pharmaceuticals.
VCs Serena and Isai re-up, having previously backed the €5m series-A in 2016
Third investment made by Alto Capital IV, which held a €210m final close in 2018
Based in London and Frankfurt, Wunderlin will report to group chief executive Peter Harrison
Ardian bought a majority stake in France-based Revima from Argos Wityu last month